Form4insider filings, from the source

Insider holders · CIK 0001533743

Processa Pharmaceuticals, Inc. · PCSA

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
David YoungPres. Research & Development21,7291,00922,738Jul 1, 2026 · 4:16 pm EDTForm 4
George K NgChief Executive Officer17,09280017,892Aug 11, 2026 · 4:21 pm EDTForm 4
Russell SkibstedChief Financial Officer16,689—16,689Jul 28, 2026 · 8:29 pm EDTForm 4
Patrick LinChief Business - Strategy Off13,1131,74014,853Jul 28, 2026 · 8:23 pm EDTForm 4
Wendy GuyChief Administrative Officer14,39433314,727Jul 28, 2026 · 8:22 pm EDTForm 4
Khoso BaluchDirector2,528—2,528Jul 28, 2026 · 8:19 pm EDTForm 4
Geraldine PannuDirector2,391—2,391Jul 28, 2026 · 8:27 pm EDTForm 4
James R NealDirector1,021—1,021Jul 28, 2026 · 8:25 pm EDTForm 4
Justin W YorkeDirector353496849Jul 28, 2026 · 8:31 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.